立即释放与延长释放的塔克罗利木斯:在脏移植接受者中比较血压控制 - 一项回顾性队列研究
Chien-Wen Yang1,2, Juan Carlos Q Velez1,2, Debbie L Cohen3
1Department of Nephrology, Ochsner Medical Center, New Orleans, Louisiana, USA.
Nephron
|September 22, 2024
概括
延长释放塔克罗利莫斯 (Tac ER) 和即时释放塔克罗利莫斯 (Tac IR) 在脏移植患者中显示出类似的长期血压控制. 这项研究发现,这两种塔克罗利斯配方之间的静缩或静缩血压没有显著差异.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 高血压是移植接受者治疗塔克罗利斯 (Tac) 的常见并发症.
- 立即释放塔克罗利莫斯 (Tac IR) 和延长释放塔克罗利莫斯 (Tac ER) 之间的长期血压控制差异尚未得到充分证实.
- 塔克罗利马斯是预防移植排斥的主要免疫抑制剂.
研究的目的:
- 为了比较Tac IR与Tac ER对移植患者长期血压控制的影响.
- 为了评估系统血压 (SBP),透气血压 (DBP) 和Tac IR和Tac ER之间的高血压危机的差异.
- 分析TACROLIMUS配方对移植后血压管理的影响.
主要方法:
- 一项回顾性队列研究分析了654名脏移植接受者.
- 对于接受Tac IR或Tac ER的患者,收集了SBP,DBP和高血压危机的纵向数据.
- 使用边缘结构线性混合效应模型来评估血压控制.
主要成果:
- 在Tac IR和Tac ER组之间没有观察到纵向静脉血压 (p = 0.386) 或静脉血压 (p = 0.797) 的显著差异.
- 该研究包括了平均年龄在50-52岁左右的患者,性别分布相似.
- 黑人患者接受Tac ER的几率更高,即使在根据基线特征进行调整后.
结论:
- 延长释放塔克罗利斯 (Tac ER) 在脏移植接受者中不会导致与即时释放塔克罗利斯 (Tac IR) 相比不同的慢性缩或腹缩血压控制.
- 在这种人群中,Tac IR和Tac ER之间的选择可能不会显著影响长期血压管理.
- 进一步的研究可以探索其他潜在的差异或患者子组.
相关概念视频
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...